This issue of the journal is dedicated to targeted delivery of therapeutics in the vasculature,
an approach that holds promise to optimize treatment of diverse pathological conditions …

Nanomedicine approaches have revolutionized the treatment of cancer and vascular
diseases, where the limitations of rapid nonspecific clearance, poor biodistribution and …

Vascular‐targeted nanocarriers are an attractive option for the treatment of a number of
cardiovascular diseases, as they allow for more specific delivery and increased efficacy of …

The bloodstream is the main transporting pathway for drug delivery systems (DDS) from the
site of administration to the intended site of action. In many cases, components of the …

Cardiovascular and cerebrovascular diseases (CCVD) are a major and increasing health
burden worldwide. Although treatments have been made a certain progress, the …

Vascular-targeted drug delivery systems could provide more efficient and effective
pharmaceutical interventions for treating a variety of diseases including cardiovascular …

The long cherished goal of targeting drugs to specific sites in the body, where the
pharmacological action is desired and sparing other tissues has been actively pursued all …

Conventional drug therapies suffer from several limitations most prominently the
pharmacokinetic alterations in biological systems, which result in decreased bioavailability …

This review discusses the challenges associated with drug delivery and benefits of
employing nanosystems in the delivery of small and macromolecular drugs. Poor …

The term “nanotechnology” was coined by Norio Taniguchi in the 1970s to describe the
manipulation of materials at the nano (10− 9) scale, and the term “nanomedicine” was put …